Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001615774-19-002599
Filing Date
2019-02-15
Accepted
2019-02-15 07:48:46
Documents
2
Period of Report
2019-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 s116178_form3.html 3  
1 FORM 3 s116178_form3.xml 3 2234
2 EXHIBIT 24 s116178_ex24.htm EX-24 6233
  Complete submission text file 0001615774-19-002599.txt   9866
Mailing Address 285 GRAND AVENUE ENGLEWOOD NJ 07631
Business Address
MATS VADIM (Reporting) CIK: 0001546594 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38803 | Film No.: 19609859

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Issuer) CIK: 0001711786 (see all company filings)

EIN.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations